Answers are grounded in this paper and cite their sources.
Analysis reveals higher sexual adverse events with finasteride compared to dutasteride, suggesting nocebo influence.
Our findings support that the disproportionately higher reporting of sexual AEs with finasteride 1 mg than with dutasteride 0.5 mg-even more so after 2012-could be attributed to the nocebo effect.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: